Medical data and text mining: Linking diseases, drugs, and adverse reactions
•Download as PPT, PDF•
1 like•558 views
Medical data and text mining: Linking diseases, drugs, and adverse reactions
Recommended
Recommended
More Related Content
What's hot
What's hot (18)
Similar to Medical data and text mining: Linking diseases, drugs, and adverse reactions
Similar to Medical data and text mining: Linking diseases, drugs, and adverse reactions (20)
More from Lars Juhl Jensen
More from Lars Juhl Jensen (20)
Recently uploaded
Recently uploaded (20)
Medical data and text mining: Linking diseases, drugs, and adverse reactions
- 1. Medical data and text mining Linking diseases, drugs, and adverse reactions Lars Juhl Jensen
- 3. Jensen et al., Nature Reviews Genetics, 2012
- 9. opt-out
- 10. opt-in
- 13. CPR number
- 15. Jensen et al., Nature Reviews Genetics, 2012
- 17. 14 years
- 22. ICD-10
- 23. Jensen et al., Nature Reviews Genetics, 2012
- 24. not research
- 25. reimbursement
- 27. naïve approach
- 28. comorbidity
- 29. Jensen et al., Nature Reviews Genetics, 2012
- 31. “known knowns”
- 32. gender
- 33. age
- 34. type of hospital encounter
- 35. Jensen et al., Nature Communications, 2014
- 36. “known unknowns”
- 37. smoking
- 38. diet
- 40. reporting biases
- 41. matched controls
- 43. multiple testing
- 44. trajectories
- 45. Jensen et al., Nature Communications, 2014
- 47. Jensen et al., Nature Communications, 2014
- 48. key diagnoses
- 49. Jensen et al., Nature Communications, 2014
- 52. structured data
- 53. Jensen et al., Nature Reviews Genetics, 2012
- 56. free text
- 57. Danish
- 58. busy doctors
- 59. typos
- 61. text mining
- 63. drugs
- 65. expansion rules
- 66. Clozapine
- 67. Clozapine clozapi n clossapi n klozapin e chlosapi n chlozapi chlosapi ne n chlozapi ne klossapi n closapin e klozapi klosapi n n
- 70. renal failure
- 72. clinical trials
- 75. underreporting
- 76. data mining
- 77. structured data
- 78. medication
- 80. drug indications
- 81. known ADRs
- 86. Drug introduction Adverse event Drug discontinuation Negative modifier Indication Pre-existing Adverse event Eriksson et al., Drug Safety, 2014 condition Adverse drug reaction Possible adverse drug reaction ADR of additional drug
- 87. Drug introduction Identification star t Adverse event Drug discontinuation Negative modifier Indication Pre-existing Adverse event Eriksson et al., Drug Safety, 2014 condition Adverse drug reaction Possible adverse drug reaction ADR of additional drug
- 88. Drug introduction Drug discontinuation Negative modifier Indication Pre-existing Adverse event Eriksson et al., Drug Safety, 2014 condition Adverse drug reaction Possible adverse drug reaction Adverse event ADR of additional drug Identification star t
- 89. Drug introduction Drug discontinuation Negative modifier Indication Pre-existing Adverse event Eriksson et al., Drug Safety, 2014 condition Adverse drug reaction Possible adverse drug reaction Adverse event ADR of additional drug Identification star t
- 92. Eriksson et al., Drug Safety, 2014
- 94. Drug substance ADE p-value Chlordiazepoxide Nystagmus 4.0e-8 Simvastatin Personality changes 8.4e-8 Dipyridamole Visual impairment 4.4e-4 Citalopram Psychosis 8.8e-4 Bendroflumethiazi Apoplexy 8.5e-3 de Eriksson et al., Drug Safety, 2014
- 95. Acknowledgments Disease trajectories Anders Bøck Jensen Tudor Oprea Pope Moseley Søren Brunak Adverse drug reactions Robert Eriksson Thomas Werge Søren Brunak EHR text mining Peter Bjødstrup Jensen Robert Eriksson Henriette Schmock Francisco S. Roque Anders Juul Marlene Dalgaard Massimo Andreatta Sune Frankild Eva Roitmann Thomas Hansen Karen Søeby Søren Bredkjær Thomas Werge Søren Brunak